Serial Number | 97296549 |
Word Mark | NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES |
Filing Date | Friday, March 4, 2022 |
Status | 700 - REGISTERED |
Status Date | Tuesday, May 23, 2023 |
Registration Number | 7064074 |
Registration Date | Tuesday, May 23, 2023 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Scientific research and development in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; research and product development services for others in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; Medical and scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease detection; Providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, March 9, 2022 |
Primary Code | 042 |
First Use Anywhere Date | Friday, January 10, 2020 |
First Use In Commerce Date | Friday, January 10, 2020 |
Party Name | Angiex, Inc. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02140 |
Party Name | Angiex, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02140 |
Event Date | Event Description |
Tuesday, May 23, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, May 23, 2023 | REGISTERED-SUPPLEMENTAL REGISTER |
Friday, April 21, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Friday, April 21, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Friday, April 21, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
Friday, April 21, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Friday, April 21, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Friday, April 21, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Monday, April 17, 2023 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Wednesday, April 12, 2023 | ASSIGNED TO LIE |
Friday, March 31, 2023 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
Thursday, March 30, 2023 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
Thursday, March 30, 2023 | USE AMENDMENT ACCEPTED |
Tuesday, March 7, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, March 6, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, March 6, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, March 7, 2023 | AMENDMENT TO USE PROCESSING COMPLETE |
Tuesday, March 7, 2023 | USE AMENDMENT FILED |
Monday, March 6, 2023 | TEAS AMENDMENT OF USE RECEIVED |
Thursday, December 22, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, December 22, 2022 | NON-FINAL ACTION E-MAILED |
Thursday, December 22, 2022 | NON-FINAL ACTION WRITTEN |
Thursday, December 15, 2022 | ASSIGNED TO EXAMINER |
Wednesday, March 9, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, March 8, 2022 | NEW APPLICATION ENTERED |